Wednesday, November 12, 2025

Wednesday, November 12, 2025

Center for Science in the Public Interest News

No Results

Trending

  1. 1 GBM: Glioblastoma Multiforme Treatments Advancing as FDA Steps Up Measures Due to Rising Incidences
  2. 2 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
FDA Health News